DeSantis Robert - Jul 23, 2021 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
EVP & Chief Product Officer
Signature
By: Donna Spinola For: Robert DeSantis
Stock symbol
ISRG
Transactions as of
Jul 23, 2021
Transactions value $
-$3,035,650
Form type
4
Date filed
7/26/2021, 07:44 PM
Next filing
Aug 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $352K +484 +16.25% $727.01 3.46K Jul 23, 2021 Direct F1
transaction ISRG Common Stock Sale -$468K -484 -13.98% $967.21 2.98K Jul 23, 2021 Direct F1, F2
transaction ISRG Common Stock Options Exercise $228K +422 +14.17% $539.10 3.4K Jul 23, 2021 Direct F1
transaction ISRG Common Stock Sale -$408K -422 -12.41% $967.23 2.98K Jul 23, 2021 Direct F1, F2
transaction ISRG Common Stock Options Exercise $258K +483 +16.22% $533.96 3.46K Jul 23, 2021 Direct F1
transaction ISRG Common Stock Sale -$467K -483 -13.96% $967.23 2.98K Jul 23, 2021 Direct F1, F2
transaction ISRG Common Stock Sale -$2.53M -2.62K -87.81% $967.29 363 Jul 23, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -483 -33.31% $0.00 967 Jul 23, 2021 Common Stock 483 $533.96 Direct F1, F3
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -422 -29.14% $0.00 1.03K Jul 23, 2021 Common Stock 422 $539.10 Direct F1, F4
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -484 -33.4% $0.00 965 Jul 23, 2021 Common Stock 484 $727.01 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $962.83 to $975.41,inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F4 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time.
F5 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.